Technical Analysis for PRME - Prime Medicine, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bullish Engulfing | Bullish | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Stochastic Buy Signal | Bullish | 6.61% | |
| Volume Surge | Other | 6.61% | |
| Wide Bands | Range Expansion | 6.61% | |
| Oversold Stochastic | Weakness | 6.61% | |
| Lower Bollinger Band Walk | Weakness | 2.81% | |
| Wide Bands | Range Expansion | 2.81% | |
| Lower Bollinger Band Touch | Weakness | 2.81% |
| Alert | Time |
|---|---|
| Possible NR7 | about 6 hours ago |
| Up 5% | about 8 hours ago |
| Rose Above Previous Day's High | about 8 hours ago |
| Up 3% | about 10 hours ago |
| 60 Minute Opening Range Breakout | about 10 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Prime Medicine is a biotechnology company committed to delivering a new class of differentiated, one-time, curative genetic therapies to address the widest spectrum of diseases. The company is deploying Prime Editing technology, a versatile, precise, efficient and broad gene editing technology, which is designed to make only the right edit at the right position within a gene. With the theoretical potential to repair approximately 90 percent of known disease-causing genetic mutations across many organs and cell types, medicines based on Prime Editing, if approved, could offer a one-time curative genetic therapeutic option to a broad set of patients.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Disease Emerging Technologies Molecular Biology Medical Genetics Genetic Engineering Gene Editing Gene Editing Technology
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Disease Emerging Technologies Molecular Biology Medical Genetics Genetic Engineering Gene Editing Gene Editing Technology
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 15.7485 |
| 52 Week Low | 4.11 |
| Average Volume | 1,000,050 |
| 200-Day Moving Average | 7.34 |
| 50-Day Moving Average | 6.14 |
| 20-Day Moving Average | 6.44 |
| 10-Day Moving Average | 5.79 |
| Average True Range | 0.52 |
| RSI (14) | 41.18 |
| ADX | 21.98 |
| +DI | 18.25 |
| -DI | 30.77 |
| Chandelier Exit (Long, 3 ATRs) | 6.58 |
| Chandelier Exit (Short, 3 ATRs) | 6.55 |
| Upper Bollinger Bands | 8.06 |
| Lower Bollinger Band | 4.81 |
| Percent B (%b) | 0.21 |
| BandWidth | 50.55 |
| MACD Line | -0.32 |
| MACD Signal Line | -0.12 |
| MACD Histogram | -0.1983 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 6.19 | ||||
| Resistance 3 (R3) | 6.13 | 5.85 | 6.07 | ||
| Resistance 2 (R2) | 5.85 | 5.67 | 5.87 | 6.03 | |
| Resistance 1 (R1) | 5.66 | 5.56 | 5.76 | 5.72 | 5.99 |
| Pivot Point | 5.38 | 5.38 | 5.42 | 5.40 | 5.38 |
| Support 1 (S1) | 5.19 | 5.20 | 5.29 | 5.25 | 4.97 |
| Support 2 (S2) | 4.91 | 5.09 | 4.93 | 4.93 | |
| Support 3 (S3) | 4.72 | 4.91 | 4.89 | ||
| Support 4 (S4) | 4.78 |
